Axsome Therapeutics, INC. 4 Filing

Ticker: AXSM · Form: 4 · Filed: Apr 24, 2026 · CIK: 0001579428

Axsome Therapeutics, INC. 4 Filing Summary
FieldDetail
CompanyAxsome Therapeutics, INC. (AXSM)
Form Type4
Filed DateApr 24, 2026
Sentimentneutral

Sentiment: neutral

FAQ

What type of filing is this?

This is a 4 filing submitted by Axsome Therapeutics, INC. (ticker: AXSM) to the SEC on Apr 24, 2026.

Where can I view the full 4 filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Details

This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 24, 2026 regarding Axsome Therapeutics, Inc. (AXSM). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.

View full filing on EDGAR

View Full Filing

View this 4 filing on SEC EDGAR

View on Read The Filing